Jorge Palacios

Jorge Palacios

Auto-generated profile, based on publicly available information

Jorge Palacios

Bright Therapeutics, San Francisco, CA, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
NMN. Mehta
N. Mehta
SCS. Clement
S. Clement
EMElena Marcus
Elena Marcus
ASA.-C. Stona
A.-C. Stona
NBNikita Bezborodovs
Nikita Bezborodovs
.... ..
.. ..
Background: Most research on interventions to counter stigma and discrimination has focused on short-term outcomes and has been conducted in high-income settings.Aims: To synthesise what is known globally about effective interventions to reduce mental illness-based stigma and discrimination, in relation first to effectiveness in the medium and long term (minimum 4 weeks), and second to interventions in low- and middle-income countries (LMICs).Method: We searched six databases from 1980 to 2013 and conducted a multi-language Google search for quantitative studies addressing the research questions. Effect sizes were calculated from eligible studies where possible, and narrative syntheses conducted. Subgroup analysis compared interventions with and without social contact.Results: Eighty studies (n = 422 653) were included in the review. For studies with medium or long-term follow-up (72, of which 21 had calculable effect sizes) median standardised mean differences were 0.54 for knowledge and −0.26 for stigmatising attitudes. Those containing social contact (direct or indirect) were not more effective than those without. The 11 LMIC studies were all from middle-income countries. Effect sizes were rarely calculable for behavioural outcomes or in LMIC studies.Conclusions: There is modest evidence for the effectiveness of anti-stigma interventions beyond 4 weeks follow-up in terms of increasing knowledge and reducing stigmatising attitudes. Evidence does not support the view that social contact is the more effective type of intervention for improving attitudes in the medium to long term. Methodologically strong research is needed on which to base decisions on investment in stigma-reducing interventions.

17 March 2023 in ACM Transactions on Computer-Human Interaction
Verified
Journal Article
Open access
Anja ThiemeAnja Thieme
Anja Thieme
MHMaryann Hanratty
Maryann Hanratty
MLMaria Lyons
Maria Lyons
JPJorge E. Palacios
Jorge E. Palacios
RMRita Faia Marques
Rita Faia Marques
GDGavin Doherty
Gavin Doherty
Recent advances in AI and machine learning (ML) promise significant transformations in the future delivery of healthcare. Despite a surge in research and development, few works have moved beyond demonstrations of technical feasibility and algorithmic performance. However, to realize many of the ambitious visions for how AI can contribute to clinical impact requires the closer design and study of AI tools or interventions within specific health and care contexts. This article outlines our collaborative, human-centered approach to developing an AI application that predicts treatment outcomes for patients who are receiving human-supported, internet-delivered Cognitive Behavioral Therapy (iCBT) for symptoms of depression and anxiety. Intersecting the fields of HCI, AI, and healthcare, we describe how we addressed the specific challenges of (1) identifying clinically relevant AI applications ; and (2) designing AI applications for sensitive use contexts like mental health. Aiming to better assist the work practices of iCBT supporters, we share how learnings from an interview study with 15 iCBT supporters surfaced their practices and information needs and revealed new opportunities for the use of AI. Combined with insights from the clinical literature and technical feasibility constraints, this led to the development of two clinical outcome prediction models. To clarify their potential utility for use in practice, we conducted 13 design sessions with iCBT supporters that utilized interface mock-ups to concretize the AI output and derive additional design requirements. Our findings demonstrate how design choices can impact interpretations of the AI predictions as well as supporter motivation and sense of agency. We detail how this analysis and the design principles derived from it enabled the integration of the prediction models into a production interface. Reporting on identified risks of over-reliance on AI outputs and needs for balanced information assessment and preservation of a focus on individualized care, we discuss and reflect on what constitutes a responsible, human-centered approach to AI design in this healthcare context.

1 January 2018 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
JPJorge Palacios
Jorge Palacios
MKMizanur Khondoker
Mizanur Khondoker
AMAnthony Mann
Anthony Mann
ATAndre Tylee
Andre Tylee
MHMatthew Hotopf
Matthew Hotopf

1 August 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AEAngel Enrique
Angel Enrique
JPJorge E Palacios
Jorge E Palacios
HRHolly Ryan
Holly Ryan
DRDerek Richards
Derek Richards
Background: Internet interventions can easily generate objective data about program usage. Increasingly, more studies explore the relationship between usage and outcomes, but they often report different metrics of use, and the findings are mixed. Thus, current evaluations fail to demonstrate which metrics should be considered and how these metrics are related to clinically meaningful change. Objective: This study aimed to explore the relationship between several usage metrics and outcomes of an internet-based intervention for depression. Methods: This is a secondary analysis of data from a randomized controlled trial that examined the efficacy of an internet-based cognitive behavioral therapy for depression (Space from Depression) in an adult community sample. All participants who enrolled in the intervention, regardless of meeting the inclusion criteria, were included in this study. Space from Depression is a 7-module supported intervention, delivered over a period of 8 weeks. Different usage metrics (ie, time spent, modules and activities completed, and percentage of program completion) were automatically collected by the platform, and composite variables from these (eg, activities per session) were computed. A breakdown of the usage metrics was obtained by weeks. For the analysis, the sample was divided into those who obtained a reliable change (RC)—and those who did not. Results: Data from 216 users who completed pre- and posttreatment outcomes were included in the analyses. A total of 89 participants obtained an RC, and 127 participants did not obtain an RC. Those in the RC group significantly spent more time, had more log-ins, used more tools, viewed a higher percentage of the program, and got more reviews from their supporter compared with those who did not obtain an RC. Differences between groups in usage were observed from the first week in advance across the different metrics, although they vanished over time. In the RC group, the usage was higher during the first 4 weeks, and then a significant decrease was observed. Our results showed that specific levels of platform usage, 7 hours total time spent, 15 sessions, 30 tools used, and 50% of program completion, were associated with RC. Conclusions: Overall, the results showed that those individuals who obtained an RC after the intervention had higher levels of exposure to the platform. The usage during the first half of the intervention was higher, and differences between groups were observed from the first week. This study also showed specific usage levels associated with outcomes that could be tested in controlled studies to inform the minimal usage to establish adherence. These results will help to better understand how to use internet-based interventions and what optimal level of engagement can most affect outcomes. Trial Registration: ISRCTN Registry ISRCTN03704676; http://www.isrctn.com/ISRCTN03704676 International Registered Report Identifier (IRRID): RR2-10.1186/1471-244X-14-147

1 July 2017 in Journal of Cardiovascular Nursing
Verified
Journal Article
Open access
PDF file
JPJorge Palacios
Jorge Palacios
GLGeraldine A. Lee
Geraldine A. Lee
MDMaria Duaso
Maria Duaso
ACAbigail Clifton
Abigail Clifton
INIan J. Norman
Ian J. Norman
EBElizabeth Alexandra Barley
Elizabeth Alexandra Barley
Introduction: Coronary heart disease (CHD) is associated with significant morbidity and mortality, including mental health comorbidity, which is associated with poor outcomes. Self-management is key, but there is limited access to self-management support. Internet-delivered interventions may increase access. Objective: The aim of this study was to conduct a systematic review to (1) determine the effectiveness of Internet-delivered CHD self-management support for improving CHD, mood, and self-management related outcomes and (2) identify and describe essential components for effectiveness. Method: Randomized controlled trials that met prespecified eligibility criteria were identified using a systematic search of 3 healthcare databases (Medline, PsychINFO, and Embase). Results: Seven trials, which included 1321 CHD patients, were eligible for inclusion. There was considerable heterogeneity between studies in terms of the intervention content, outcomes measured, and study quality. All 7 of the studies reported significant positive between-group effects, in particular for lifestyle-related outcomes. Personalization of interventions and provision of support to promote engagement may be associated with improved outcomes, although more data are required to confirm this. The theoretical basis of interventions was poorly developed though evidence-based behavior change interventions were used. Conclusion: More well-designed randomized controlled trials are needed. These should also explore how interventions work and how to improve participant retention and satisfaction and examine the role of personalization and support within interventions.

2 March 2018 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
DRDerek Richards
Derek Richards
DDDaniel Duffy
Daniel Duffy
BBBrid Blackburn
Brid Blackburn
CECaroline Earley
Caroline Earley
AEAngel Enrique
Angel Enrique
LTLadislav Timulak
Ladislav Timulak
Depression and anxiety are common mental health disorders worldwide. The UK’s Improving Access to Psychological Therapies (IAPT) programme is part of the National Health Service (NHS) designed to provide a stepped care approach to treating people with anxiety and depressive disorders. Cognitive Behavioural Therapy (CBT) is widely used, with computerised and internet-delivered cognitive behavioural therapy (cCBT and iCBT, respectively) being a suitable IAPT approved treatment alternative for step 2, low- intensity treatment. iCBT has accumulated a large empirical base for treating depression and anxiety disorders. However, the cost-effectiveness and impact of these interventions in the longer-term is not routinely assessed by IAPT services. The current study aims to evaluate the clinical and cost-effectiveness of internet-delivered interventions for symptoms of depression and anxiety disorders in IAPT. The study is a parallel-groups, randomised controlled trial examining the effectiveness and cost-effectiveness of iCBT interventions for depression and anxiety disorders, against a waitlist control group. The iCBT treatments are of 8 weeks duration and will be supported by regular post-session feedback by Psychological Wellbeing Practitioners. Assessments will be conducted at baseline, during, and at the end of the 8-week treatment and at 3, 6, 9, and 12-month follow-up. A diagnostic interview will be employed at baseline and 3-month follow-up. Participants in the waitlist control group will complete measures at baseline and week 8, at which point they will receive access to the treatment. All adult users of the Berkshire NHS Trust IAPT Talking Therapies Step 2 services will be approached to participate and measured against set eligibility criteria. Primary outcome measures will assess anxiety and depressive symptoms using the GAD-7 and PHQ-9, respectively. Secondary outcome measures will allow for the evaluation of long-term outcomes, mediators and moderators of outcome, and cost-effectiveness of treatment. Analysis will be conducted on a per protocol and intention-to-treat basis. This study seeks to evaluate the immediate and longer-term impact, as well as the cost effectiveness of internet-delivered interventions for depression and anxiety. This study will contribute to the already established literature on internet-delivered interventions worldwide. The study has the potential to show how iCBT can enhance service provision, and the findings will likely be generalisable to other health services. Current Controlled Trials ISRCTN ISRCTN91967124. DOI: https://doi.org/10.1186/ISRCTN91967124 . Web: http://www.isrctn.com/ISRCTN91967124 . Clinicaltrials.gov : NCT03188575. Trial registration date: June 8, 2017 (prospectively registered).